Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, Spero Therapeutics Inc (NASDAQ: SPRO) closed at $0.94 up 1.59% from its previous closing price of $0.92. In other words, the price has increased by $1.59 from its previous closing price. On the day, 0.22 million shares were traded. SPRO stock price reached its highest trading level at $0.947 during the session, while it also had its lowest trading level at $0.9196.
Ratios:
For a deeper understanding of Spero Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.68 and its Current Ratio is at 2.68. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.04.
On September 23, 2022, Evercore ISI Upgraded its rating to Outperform which previously was In-line and also upped its target price recommendation from $2 to $8.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 07 ’24 when Rajavelu Esther sold 23,351 shares for $1.31 per share. The transaction valued at 30,590 led to the insider holds 396,515 shares of the business.
Rajavelu Esther sold 17,245 shares of SPRO for $22,418 on Nov 08 ’24. The CFO & CBO now owns 379,270 shares after completing the transaction at $1.30 per share. On Aug 27 ’24, another insider, Mahadevia Ankit, who serves as the Director of the company, sold 5,912 shares for $1.35 each. As a result, the insider received 7,981 and left with 759,085 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SPRO now has a Market Capitalization of 51110812 and an Enterprise Value of 5188984. As of this moment, Spero’s Price-to-Earnings (P/E) ratio for their current fiscal year is 11.59. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.31. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.56 while its Price-to-Book (P/B) ratio in mrq is 0.76. Its current Enterprise Value per Revenue stands at 0.044 whereas that against EBITDA is 0.247.
Stock Price History:
Over the past 52 weeks, SPRO has reached a high of $1.89, while it has fallen to a 52-week low of $0.92. The 50-Day Moving Average of the stock is -21.01%, while the 200-Day Moving Average is calculated to be -31.90%.
Shares Statistics:
For the past three months, SPRO has traded an average of 266.64K shares per day and 265330 over the past ten days. A total of 54.31M shares are outstanding, with a floating share count of 39.50M. Insiders hold about 27.54% of the company’s shares, while institutions hold 19.35% stake in the company. Shares short for SPRO as of 1730332800 were 625191 with a Short Ratio of 1.85, compared to 1727654400 on 384302. Therefore, it implies a Short% of Shares Outstanding of 625191 and a Short% of Float of 1.4099999.
